174 related articles for article (PubMed ID: 37394531)
1. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
Yang P; Mao Z; Sun M; Guo J
Eur J Pediatr; 2023 Sep; 182(9):4049-4057. PubMed ID: 37394531
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
[TBL] [Abstract][Full Text] [Related]
3. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
Zhang H; Song HB; Wang DX; Deng HY; Sun WL
Pak J Med Sci; 2022; 38(5):1165-1169. PubMed ID: 35799766
[TBL] [Abstract][Full Text] [Related]
7. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M
PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185
[TBL] [Abstract][Full Text] [Related]
9. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
[TBL] [Abstract][Full Text] [Related]
12. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for coronary artery lesions in children with Kawasaki disease.
Duan J; Jiang H; Lu M
Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
[TBL] [Abstract][Full Text] [Related]
15. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.
Kim MK; Song MS; Kim GB
Korean Circ J; 2018 Jan; 48(1):71-79. PubMed ID: 29171205
[TBL] [Abstract][Full Text] [Related]
16. [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].
Hu HM; Chen XZ; Zhang YL; DU ZD
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):681-686. PubMed ID: 35762436
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
18. C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.
Tsai CM; Yu HR; Tang KS; Huang YH; Kuo HC
Front Pediatr; 2020; 8():607631. PubMed ID: 33324592
[No Abstract] [Full Text] [Related]
19. [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].
Wang X; Pan SL; DU ZH; Ji ZX; Luo G; Sun HX; Ma SJ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr; 24(4):399-404. PubMed ID: 35527415
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]